Protein aggregation, misfolding and consequential human neurodegenerative diseases

被引:42
|
作者
Sami, Neha [1 ]
Rahman, Safikur [2 ]
Kumar, Vijay [1 ]
Zaidi, Sobia [1 ]
Islam, Asimul [1 ]
Ali, Sher [1 ]
Ahmad, Faizan [1 ]
Hassan, Md. Imtaiyaz [1 ]
机构
[1] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India
[2] Yeungnam Univ, Dept Med Biotechnol, Gyongsan, South Korea
关键词
Protein misfolding; aggregation; amyloids; pathomechanisms; amyotrophic lateral sclerosis; stem cell; AMYOTROPHIC-LATERAL-SCLEROSIS; LOSS-OF-FUNCTION; FRONTOTEMPORAL LOBAR DEGENERATION; STEM-CELL TRANSPLANTATION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; GENE-THERAPY; CHEMICAL CHAPERONES; AMYLOID FIBRILS;
D O I
10.1080/00207454.2017.1286339
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Proteins are major components of the biological functions in a cell. Biology demands that a protein must fold into its stable three-dimensional structure to become functional. In an unfavorable cellular environment, protein may get misfolded resulting in its aggregation. These conformational disorders are directly related to the tissue damage resulting in cellular dysfunction giving rise to different diseases. This way, several neurodegenerative diseases such as Alzheimer, Parkinson Huntington diseases and amyotrophic lateral sclerosis are caused. Misfolding of the protein is prevented by innate molecular chaperones of different classes. It is envisaged that work on this line is likely to translate the knowledge into the development of possible strategies for early diagnosis and efficient management of such related human diseases. The present review deals with the human neurodegenerative diseases caused due to the protein misfolding highlighting pathomechanisms and therapeutic intervention.
引用
收藏
页码:1047 / 1057
页数:11
相关论文
共 50 条
  • [31] Targeting protein aggregation for the treatment of neurodegenerative diseases
    Qingchao Li
    Wei Pan
    Jun Zhou
    Haiyang Yu
    Songbo Xie
    Medicine Plus, 2024, 1 (01) : 68 - 72
  • [32] Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases
    Nakamura, Tomohiro
    Lipton, Stuart A.
    ANTIOXIDANTS & REDOX SIGNALING, 2008, 10 (01) : 87 - 101
  • [33] Neurometals as modulators of protein aggregation in neurodegenerative diseases
    Leal, Sonia S.
    Cristovao, Joana S.
    Gomes, Claudio M.
    PROTEIN SCIENCE, 2015, 24 : 92 - 92
  • [34] NEURODEGENERATIVE DISEASE Phosphatase inhibitor prevents protein-misfolding diseases
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (06) : 386 - 386
  • [35] Protein Misfolding and Aggregation in the Brain: Common Pathogenetic Pathways in Neurodegenerative and Mental Disorders
    Ochneva, Aleksandra
    Zorkina, Yana
    Abramova, Olga
    Pavlova, Olga
    Ushakova, Valeriya
    Morozova, Anna
    Zubkov, Eugene
    Pavlov, Konstantin
    Gurina, Olga
    Chekhonin, Vladimir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [36] Chemical and biological approaches for the treatment of protein misfolding and aggregation diseases
    Cooley, Christina
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [37] Protein misfolding and aggregation
    Murphy, Regina M.
    Kendrick, Brent S.
    BIOTECHNOLOGY PROGRESS, 2007, 23 (03) : 548 - 552
  • [38] Protein folding, misfolding and aggregation: Evolving concepts and conformational diseases
    Ramos, CHI
    Ferreira, ST
    PROTEIN AND PEPTIDE LETTERS, 2005, 12 (03): : 213 - 222
  • [39] Therapeutic approaches to polyglutamine diseases: Combating protein misfolding and aggregation
    Herbst, Martin
    Wanker, Erich E.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (20) : 2543 - 2555
  • [40] Protein Folding, Misfolding, Aggregation and Their Implications in Human Diseases: Discovering Therapeutic Ways to Amyloid-Associated Diseases
    Iram, Afshin
    Naeem, Aabgeena
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (01) : 51 - 61